Immy, Myco DDR Trident, Bulk Neutralization Buffer B (60 X 30 mL), REF: TBPN67-60 For processing...

FDA Device Recall #Z-1984-2026 - Class II, March 26, 2026

Recall Summary

Recall Number Z-1984-2026
Classification Class II - Moderate risk
Date Initiated March 26, 2026
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Immuno-Mycologics, Inc
Location Norman, OK
Product Type Devices
Quantity 101 units

Product Description

Immy, Myco DDR Trident, Bulk Neutralization Buffer B (60 X 30 mL), REF: TBPN67-60 For processing of clinical specimens for Mycobacterium spp. diagnosis

Reason for Recall

Neutralization Buffer may contain contaminants

Distribution Pattern

US Nationwide distribution in the states of AZ, MS, SC, CT, NC, TX, IN, WA, MO, MI, CA.

Lot / Code Information

Lot: F5061154/UDI: 00816387021091

Other Recalls from Immuno-Mycologics, Inc

Recall # Classification Product Date
Z-1389-2025 Class II Candida ID Antigen, REAG, AG, REF C50110, Vol 1... Feb 10, 2025
Z-0545-2022 Class II CRYPTOCOCCAL ANTIGEN LATERAL FLOW ASSAY, IMMY, ... Jan 3, 2022
Z-2301-2020 Class II Histoplasma Immunodiffusion (ID) Antigen; The I... Nov 4, 2019
Z-2409-2018 Class II Cryptococcal Antigen Lateral Flow Assay (CrAg L... Mar 30, 2018
Z-1109-2017 Class II Cryptococcal Antigen Lateral Flow Assay (CrAg L... Dec 27, 2016

Frequently Asked Questions

Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately, you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency, Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.